{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:10:39Z","timestamp":1753891839842,"version":"3.41.2"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The long non-coding RNA (lncRNA) ASAP1-IT1 has been recently shown to aberrantly increase in ovarian and bladder cancer, while its role in other malignancies remains unexplored. This study was to characterize the expression and assess the potential role of ASAP1-IT1 in hepatocellular carcinoma (HCC). Fifty-four paired HCC and histologically normal tissues were obtained from HCC patients. Human HCC cell lines (HepG2, Huh7, SMMC-7721, and BEL-7402) and a normal liver cell line (LO2) were used for <jats:italic>in vitro<\/jats:italic> studies. ASAP1-IT1-specific siRNAs were used to silence ASAP1-IT1 expression, while the pcDNA-ASAP1-IT1 vector was constructed to up-regulate its expression. In situ hybridization and qRT-PCR were performed to characterize subcellular localization and expression of ASAP1-IT1. Cell proliferation and migration assays were conducted to examine the role of ASAP1-IT1 in the progression of HCC. In silico analysis was conducted to predict putative miRNA binding sites, which were validated by luciferase reporter assays. ASAP1-IT1 levels were significantly increased in HCC tissues and cells compared with controls. Notably, higher ASAP1-IT1 levels were significantly associated with poorer prognosis of HCC patients. In situ hybridization analysis revealed that ASAP1-IT1 was mainly localized in the nucleus of hepatoma cells and differentially expressed in trabecular, compact, and pseudoglandular forms of liver cancer. Furthermore, knockdown of ASAP1-IT1 significantly suppressed cell proliferation and migration, while its overexpression significantly promoted cell proliferation and migration of HCC cells. Mechanistically, ASAP1-IT1 might exert its role in HCC progression, at least in part, by directly interacting with miR-221-3p. In conclusion, ASAP1-IT1 is abnormally elevated in HCC, and higher levels are correlated with poorer prognosis. An underlying mechanism has been proposed for ASAP1-IT1-associated promotion of proliferation and migration in HCC cells. These findings have provided evidence supporting the oncogenic role of ASAP1-IT1 in HCC.<\/jats:p>","DOI":"10.3389\/fonc.2022.746896","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T13:07:05Z","timestamp":1653916025000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Novel Role of Long Non-Coding RNA ASAP1-IT1 in Progression of Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Yanping","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengguang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyong","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honghui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Side","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and Surveillance for Hepatocellular Carcinoma: New Trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Easl Clinical Practice Guidelines: Management of Hepatocellular Carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.017","article-title":"Advances in Resection and Transplantation for Hepatocellular Carcinoma","volume":"72","author":"Vibert","year":"2020","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/mog.0000000000000626","article-title":"New Systemic Agents for Hepatocellular Carcinoma: An Update 2020","volume":"36","author":"von Felden","year":"2020","journal-title":"Curr Opin Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1249-9","article-title":"Immune-Based Therapies for Hepatocellular Carcinoma","volume":"39","author":"Pinato","year":"2020","journal-title":"Oncogene"},{"key":"B6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41392-021-00801-2","article-title":"An RNA-RNA Crosstalk Network Involving HMGB1 and RICTOR Facilitates Hepatocellular Carcinoma Tumorigenesis by Promoting Glutamine Metabolism and Impedes Immunotherapy by PD-L1+ Exosomes Activity","volume":"6","author":"Wei","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcb.29608","article-title":"Construction and Evaluation of a Prognosis lncRNA Model for Hepatocellular Carcinoma","volume":"2020","author":"Li","year":"2020","journal-title":"J Cell Biochem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12943-020-1147-3","article-title":"Emerging Role of Tumor-Related Functional Peptides Encoded by lncRNA and Circrna","volume":"19","author":"Wu","year":"2020","journal-title":"Mol Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2016.09.021","article-title":"Long non-Coding RNAs, Asap1-It1, FAM215A, and LINC00472, in Epithelial Ovarian Cancer","volume":"143","author":"Fu","year":"2016","journal-title":"Gynecol Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2017_606","article-title":"Long Noncoding RNA Asap1-IT1 Promotes Cancer Stemness and Predicts a Poor Prognosis in Patients With Bladder Cancer","volume":"64","author":"Yang","year":"2017","journal-title":"Neoplasma"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.04.015","article-title":"Lncrna ASAP1-IT1 Positively Modulates the Development of Cholangiocarcinoma Via Hedgehog Signaling Pathway","volume":"103","author":"Guo","year":"2018","journal-title":"BioMed Pharmacother"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3981","article-title":"The Emerging Role of lncRNAs in Cancer","volume":"21","author":"Huarte","year":"2015","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2020.1794239","article-title":"Long non-Coding RNA (lncRNA) and Epithelial-Mesenchymal Transition (EMT) in Colorectal Cancer: A Systematic Review","volume":"21","author":"O\u2019Brien","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"B14","article-title":"Emerging Roles of lncRNA in Cancer and Therapeutic Opportunities","volume":"9","author":"Jiang","year":"2019","journal-title":"Am J Cancer Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12943-019-1064-5","article-title":"Lncrna PVT1 Up-Regulation is a Poor Prognosticator and Serves as a Therapeutic Target in Esophageal Adenocarcinoma","volume":"18","author":"Xu","year":"2019","journal-title":"Mol Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7238","article-title":"Low Lncrna ZNF385D\u2212AS2 Expression and its Prognostic Significance in Liver Cancer","volume":"42","author":"Zhang","year":"2019","journal-title":"Oncol Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.17179\/excli2018-1541","article-title":"lncRNA Involvement in Hepatocellular Carcinoma Metastasis and Prognosis","volume":"17","author":"Abbastabar","year":"2018","journal-title":"Excli J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s167853","article-title":"LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis","volume":"11","author":"Quan","year":"2018","journal-title":"Onco Targets Ther"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3892\/br.2018.1116","article-title":"Diagnostic and Prognostic Value of Circulating Lncrna H19 in Gastric Cancer","volume":"9","author":"Y\u00f6r\u00fcker","year":"2018","journal-title":"BioMed Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.4859","article-title":"Potential Diagnostic Value of Lncrna SPRY4-IT1 in Hepatocellular Carcinoma","volume":"36","author":"Jing","year":"2016","journal-title":"Oncol Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_201801_14111","article-title":"Long non-Coding RNA Asap1-IT1 Promotes Cell Proliferation, Invasion and Metastasis Through the PTEN\/AKT Signaling Axis in non-Small Cell Lung Cancer","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.019","article-title":"MicroRNA-221 Governs Tumor Suppressor HDAC6 to Potentiate Malignant Progression of Liver Cancer","volume":"63","author":"Bae","year":"2015","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.aohep.2021.100567","article-title":"miR-221-3p Regulates Hepatocellular Carcinoma Cell Proliferation, Migration and Invasion Via Targeting LIFR","volume":"27","author":"Tan","year":"2022","journal-title":"Ann Hepatol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.11056","article-title":"miR-221-3p and miR-15b-5p Promote Cell Proliferation and Invasion by Targeting Axin2 in Liver Cancer","volume":"18","author":"Dong","year":"2019","journal-title":"Oncol Lett"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.746896\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T13:07:09Z","timestamp":1653916029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.746896\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":24,"alternative-id":["10.3389\/fonc.2022.746896"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.746896","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"article-number":"746896"}}